Back to Studies

Can doctors use blood tests and scans to give just the right radioiodine dose for thyroid cancer?

Original Title

Disease status stratification individualizes radioiodine therapy for differentiated thyroid cancer: a prospective, multicenter, real-world study

Analysis v4

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

After thyroid cancer surgery, doctors used blood tests and scans to see if any cancer was left, then gave patients one of three radioiodine treatments based on what they found.

Proposed Mechanism

No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.

Quality Analysis
Methodology
59%
Moderate QualityOverall Score
Cohort StudyMedicine

Systematic Reviews & Meta-Analyses

Max 100

Randomized Controlled Trials

Max 90

Cohort Studies

Max 72

Case-Control Studies

Max 58

Cross-Sectional Studies

Max 44

Case Reports & Case Series

Max 30

Expert Opinion & Narrative Reviews

Max 5
StrongerWeaker
Cohort Studies
Level 2
59

59 / 72

Evidence Score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Sign up free to unlock the full quality breakdown with evidence strength scoring, statistical analysis, and detailed methodology.

59%
Moderate QualityOverall Score

Publication

Authors

Qiu X, Cheng L, Jin Y, Fu H, Sa R, He Z, Luo Q, Tang L, Yang Y, Yu C, Chen L

Analysis v4
DOI:10.1186/s12885-026-16030-1
View Source

Related Content